89 related articles for article (PubMed ID: 15349656)
1. [The effect of recombinant human erythropoietin on postoperative anemia in orthognathic patients].
Xu H; Yan WM; Gen QS; Jiang H; Zhu YS
Shanghai Kou Qiang Yi Xue; 2004 Aug; 13(4):249-51. PubMed ID: 15349656
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of preoperative erythropoietin administration in pediatric neuromuscular scoliosis patients.
Vitale MG; Privitera DM; Matsumoto H; Gomez JA; Waters LM; Hyman JE; Roye DP
Spine (Phila Pa 1976); 2007 Nov; 32(24):2662-7. PubMed ID: 18007241
[TBL] [Abstract][Full Text] [Related]
3. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
Vanstraelen G; Baron F; Willems E; Bonnet C; Hafraoui K; Frère P; Fillet G; Beguin Y
Exp Hematol; 2006 Jul; 34(7):841-50. PubMed ID: 16797411
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant hematopoietins on blood-loss anemia in mice.
Jones KB; Anderson DW; Longmore GD
Iowa Orthop J; 2005; 25():129-34. PubMed ID: 16089085
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
Corapcioglu F; Aksu G; Basar EZ; Demirel A; Oncel S; Mutlu A
Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin administration in cardiac surgery.
Yazicioğlu L; Eryilmaz S; Sirlak M; Inan MB; Aral A; Taşöz R; Eren NT; Kaya B; Akalin H
J Thorac Cardiovasc Surg; 2001 Oct; 122(4):741-5. PubMed ID: 11581607
[TBL] [Abstract][Full Text] [Related]
8. [High-dose induction therapy followed by maintenance with recombinant human erythropoietin for 30 patients with tumor-related anemia].
Xu F; Zhang L; Xiang XJ; Wang ZQ; Zhou ZM; Wang SY
Ai Zheng; 2006 Sep; 25(9):1120-2. PubMed ID: 16965653
[TBL] [Abstract][Full Text] [Related]
9. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
10. Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone.
Krafft A; Bencaiova G; Breymann C
Fetal Diagn Ther; 2009; 25(2):239-45. PubMed ID: 19506383
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
[TBL] [Abstract][Full Text] [Related]
12. [Erythropoietin in the prevention and treatment of anemia in heart surgery patients].
Shevchenko IuL; Khubulava GG; Chechetkin AV; Belevitin AB; Solov'eva NIu
Vestn Khir Im I I Grek; 1999; 158(6):69-71. PubMed ID: 10709275
[TBL] [Abstract][Full Text] [Related]
13. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
14. Role of erythropoietin in anemia after heart transplantation.
Gleissner CA; Klingenberg R; Staritz P; Koch A; Ehlermann P; Wiggenhauser A; Dengler TJ
Int J Cardiol; 2006 Oct; 112(3):341-7. PubMed ID: 16309765
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317].
Georgopoulos D; Matamis D; Routsi C; Michalopoulos A; Maggina N; Dimopoulos G; Zakynthinos E; Nakos G; Thomopoulos G; Mandragos K; Maniatis A;
Crit Care; 2005 Oct; 9(5):R508-15. PubMed ID: 16277712
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of postoperative complications after orthognathic surgery: a 15-year review.
Chow LK; Singh B; Chiu WK; Samman N
J Oral Maxillofac Surg; 2007 May; 65(5):984-92. PubMed ID: 17448852
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
18. Hypertension in a pregnancy with renal anemia after recombinant human erythropoietin (rhEPO) therapy.
Kashiwagi M; Breymann C; Huch R; Huch A
Arch Gynecol Obstet; 2002 Nov; 267(1):54-6. PubMed ID: 12410378
[TBL] [Abstract][Full Text] [Related]
19. [Criteria for diagnosis and therapy of hyporegeneratory anemia in premature newborns below 33 week of gestation and body weight below 1500 grams].
Pramatarova T; Vakrilova L; Slŭncheva B; Iarŭkova N; Kalaĭdzhieva M; Emilova Z; Shishkova R; Popivanova A; Zhekova N
Akush Ginekol (Sofiia); 2007; 46 Suppl 1():63-6. PubMed ID: 18173017
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
